Guggenheim started coverage on shares of Nanobiotix (NASDAQ:NBTX – Free Report) in a research note published on Tuesday, Marketbeat.com reports. The brokerage issued a buy rating and a $64.00 price objective on the stock. A number of other analysts have also recently weighed in on the company. HC Wainwright reaffirmed a “buy” rating on shares […]

UBS Group assumed coverage on shares of Twist Bioscience (NASDAQ:TWST – Free Report) in a research note issued to investors on Wednesday, Marketbeat Ratings reports. The brokerage issued a neutral rating and a $144.00 target price on the stock. Other equities research analysts also recently issued reports about the stock. TD Cowen reissued a “buy” […]

Research analysts at B. Riley Financial initiated coverage on shares of Neuronetics (NASDAQ:STIM – Get Free Report) in a research report issued to clients and investors on Friday, Briefing.com reports. The brokerage set a “buy” rating and a $5.00 price target on the stock. B. Riley Financial’s target price indicates a potential upside of 66.11% […]

Analysts at B. Riley Financial assumed coverage on shares of Nutex Health (NASDAQ:NUTX – Get Free Report) in a report released on Friday. The firm set a “buy” rating and a $325.00 price target on the stock. B. Riley Financial’s target price indicates a potential upside of 69.50% from the stock’s current price. Several other […]